Rat Anti-NAMPT Monoclonal Antibody (14A5) (CBMAB-1711-YC)

Name: Rat Anti-NAMPT Monoclonal Antibody (14A5)
SKU: CBMAB-1711-YC
Rating: 5 (1 reviews)

See all NAMPT antibodies

Compare Online Inquiry

Datasheet

SDS

Request for COA

Datasheet Target References Q & As Review & reward Protocols Associated Products

Basic Information

Host Animal

Rat

Clone

14A5

Application

ELISA, IHC-Fr, WB

Immunogen

Synthetic peptide corresponding to Mouse Visfatin.

Specificity

Mouse, Human

Antibody Isotype

IgG2a

Application Notes

The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Format

Liquid

Purity

>95%, as determined by SDS-PAGE analysis

Storage

Store at 4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

More Infomation

Target

Full Name

Nicotinamide Phosphoribosyltransferase

Introduction

NAMPT is a protein that catalyzes the condensation of nicotinamide with 5-phosphoribosyl-1-pyrophosphate to yield nicotinamide mononucleotide, one step in the biosynthesis of nicotinamide adenine dinucleotide. The protein belongs to the nicotinic acid phosphoribosyltransferase (NAPRTase) family and is thought to be involved in many important biological processes, including metabolism, stress response and aging.

Entrez Gene ID

Human	10135
Mouse	59027

UniProt ID

Human	P43490
Mouse	Q99KQ4

Alternative Names

VF; PBEF; PBEF1; VISFATIN; 1110035O14Rik

Function

Catalyzes the condensation of nicotinamide with 5-phosphoribosyl-1-pyrophosphate to yield nicotinamide mononucleotide, an intermediate in the biosynthesis of NAD. It is the rate limiting component in the mammalian NAD biosynthesis pathway. The secreted form behaves both as a cytokine with immunomodulating properties and an adipokine with anti-diabetic properties, it has no enzymatic activity, partly because of lack of activation by ATP, which has a low level in extracellular space and plasma. Plays a role in the modulation of circadian clock function. NAMPT-dependent oscillatory production of NAD regulates oscillation of clock target gene expression by releasing the core clock component: CLOCK-ARNTL/BMAL1 heterodimer from NAD-dependent SIRT1-mediated suppression (By similarity).

Biological Process

Cell-cell signaling Source: ProtInc
Circadian regulation of gene expression Source: UniProtKB
NAD biosynthesis via nicotinamide riboside salvage pathway Source: Reactome
NAD biosynthetic process Source: GO_Central
Positive regulation of cell population proliferation Source: ProtInc
Positive regulation of nitric-oxide synthase biosynthetic process Source: BHF-UCL
Positive regulation of transcription by RNA polymerase II Source: BHF-UCL
Signal transduction Source: ProtInc

Cellular Location

Nucleus
Cytoplasm
Secreted
Note: Under non-inflammatory conditions, visfatin predominantly exhibits a granular pattern within the nucleus. Secreted by endothelial cells upon IL-1beta stimulation. Abundantly secreted in milk, reaching 100-fold higher concentrations compared to maternal serum.

Gasparrini, M., & Audrito, V. (2022). NAMPT: A critical driver and therapeutic target for cancer. The International Journal of Biochemistry & Cell Biology, 145, 106189.

Wei, Y., Xiang, H., & Zhang, W. (2022). Review of various NAMPT inhibitors for the treatment of cancer. Frontiers in Pharmacology, 13, 970553.

Ratnayake, D., Nguyen, P. D., Rossello, F. J., Wimmer, V. C., Tan, J. L., Galvis, L. A., ... & Currie, P. D. (2021). Macrophages provide a transient muscle stem cell niche via NAMPT secretion. Nature, 591(7849), 281-287.

Oka, S. I., Byun, J., Huang, C. Y., Imai, N., Ralda, G., Zhai, P., ... & Sadoshima, J. (2021). Nampt potentiates antioxidant defense in diabetic cardiomyopathy. Circulation research, 129(1), 114-130.

Heske, C. M. (2020). Beyond energy metabolism: exploiting the additional roles of NAMPT for cancer therapy. Frontiers in oncology, 9, 1514.

Galli, U., Colombo, G., Travelli, C., Tron, G. C., Genazzani, A. A., & Grolla, A. A. (2020). Recent advances in NAMPT inhibitors: a novel immunotherapic strategy. Frontiers in pharmacology, 11, 656.

Audrito, V., Messana, V. G., & Deaglio, S. (2020). NAMPT and NAPRT: two metabolic enzymes with key roles in inflammation. Frontiers in Oncology, 10, 358.

Zhang, H., Zhang, N., Liu, Y., Su, P., Liang, Y., Li, Y., ... & Yang, Q. (2019). Epigenetic regulation of NAMPT by NAMPT-AS drives metastatic progression in triple-negative breast cancer. Cancer research, 79(13), 3347-3359.

Gardell, S. J., Hopf, M., Khan, A., Dispagna, M., Hampton Sessions, E., Falter, R., ... & Pinkerton, A. B. (2019). Boosting NAD+ with a small molecule that activates NAMPT. Nature communications, 10(1), 3241.

Wang, S. N., & Miao, C. Y. (2019). Targeting NAMPT as a therapeutic strategy against stroke. Stroke and vascular neurology, svn-2018.

Ask a question We look forward to hearing from you.

0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Have you used Rat Anti-NAMPT Monoclonal Antibody (14A5)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon

$30 eGift Card
Submit a review

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols

Related Products

Mouse Anti-NAMPT Recombinant Antibody (CBT994) (CAT#: V2LY-0625-LY3116)

Rabbit Anti-NAMPT Recombinant Antibody (21HCLC) (CAT#: CBMAB-N1096-WJ)

Mouse Anti-NAMPT Recombinant Antibody (CBYC-P112) (CAT#: CBMAB-P0528-YC)

Mouse Anti-NAMPT Recombinant Antibody (CBT995) (CAT#: V2LY-0625-LY3115)

Mouse Anti-NAMPT Recombinant Antibody (CBT4046) (CAT#: V2LY-0625-LY2153)

Mouse Anti-NAMPT Recombinant Antibody (OMNI379) (CAT#: CBMAB-V0207-LY)

Rabbit Anti-NAMPT Recombinant Antibody (13H13L23) (CAT#: CBMAB-N1092-WJ)

Rabbit Anti-NAMPT Recombinant Antibody (CBWJN-1164) (CAT#: CBMAB-N1100-WJ)

Rabbit Anti-NAMPT Recombinant Antibody (CBR058F) (CAT#: CBMAB-BT063LY)

Mouse Anti-NAMPT Recombinant Antibody (CBWJN-0943) (CAT#: CBMAB-N0112-WJ)

Isotype control

For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Request bulk or custom quote Second antibody and isotype control

Contact us

Tel: (USA)
(UK)
Fax:

Global Locations

Email:

Online Inquiry